DEI Stock Analysis: Douglas Emmett | NYSE
REIT - Office | NYSE, USA | Market Cap: 2.278m USD | 12M Return: -26.4% | US25960P1093 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 15.5M
Qual. Beats: 0
Rev. Trend: 41.4%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Douglas Emmett, Inc. (DEI) is a fully integrated, self-administered and self-managed Real Estate Investment Trust (REIT) that owns and operates high-quality office and multifamily properties in the premier coastal submarkets of Los Angeles and Honolulu. The company concentrates on top-tier office assets and premier multifamily communities located in neighborhoods characterized by significant supply constraints, high-end executive housing, and key lifestyle amenities. Incorporated in 1971 and headquartered in Santa Monica, California, DEI trades on the NYSE as a mid-cap stock with a market capitalization of approximately $2.4 billion USD, having gone public in October 2006.
Classified under GICS as a Diversified REIT, Douglas Emmett operates across multiple property types-office and residential-within a single portfolio rather than focusing on a single asset class. As a U.S. REIT, the company is generally required to distribute at least 90% of its taxable income to shareholders in the form of dividends, a structural feature that makes REITs a common holding for income-oriented investors. The strategy of focusing on supply-constrained coastal submarkets reflects an emphasis on scarcity-driven demand and the long-term rental pricing power associated with densely developed, geographically limited urban areas.
- LA office occupancy declines persist amid hybrid work shift
- Honolulu multifamily rents grow on tight supply and tourism demand
- Interest rate cuts ease REIT financing costs and cap rate pressure
| Net Income: -22.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.65 > 1.0 |
| NWC/Revenue: 25.71% < 20% (prev 42.92%; Δ -17.21% < -1%) |
| CFO/TA 0.04 > 3% & CFO 429.5m > Net Income -22.9m |
| Net Debt (5.40b) to EBITDA (601.6m): 8.98 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (167.5m) vs 12m ago 0.02% < -2% |
| Gross Margin: 63.18% > 18% (prev 63.34%; Δ -0.16% > 0.5%) |
| Asset Turnover: 10.61% > 50% (prev 10.60%; Δ 0.02% > 0%) |
| Interest Coverage Ratio: 0.75 > 6 (EBIT TTM 205.6m / Interest Expense TTM 274.1m) |
| A: 0.03 (Total Current Assets 488.6m - Total Current Liabilities 229.6m) / Total Assets 9.55b |
| B: -0.16 (Retained Earnings -1.57b / Total Assets 9.55b) |
| C: 0.02 (EBIT TTM 205.6m / Avg Total Assets 9.49b) |
| D: 0.30 (Book Value of Equity 1.84b / Total Liabilities 6.04b) |
| Altman-Z'' = 0.11 = B |
| DSRI: 0.75 (Receivables 133.6m/177.1m, Revenue 1.01b/999.7m) |
| GMI: 1.00 (GM 63.34% / 63.18%) |
| AQI: 1.02 (AQ_t 0.95 / AQ_t-1 0.93) |
| SGI: 1.01 (Revenue 1.01b / 999.7m) |
| TATA: -0.05 (NI -22.9m - CFO 429.5m) / TA 9.55b) |
| Beneish M = -3.22 (Cap -4..+1) = AA |
As of September 05, 2026, the stock is trading at USD 11.42 with a total of 873,920 shares traded. Over the past week, the price has changed by -2.89%, over one month by -4.52%, over three months by -4.71% and over the past year by -26.37%.
Current recommended Stop Loss: 10.90 (which is 4.6% or 1.7 ATR below the current price).
Douglas Emmett has received a consensus analysts rating of 3.31. Therefore, it is recommended to hold DEI.
- StrongBuy: 2
- Buy: 2
- Hold: 7
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 13.1 | 14.7% |
P/E Forward = 9.0009
P/S = 2.2612
P/B = 1.0394
P/EG = 11.6749
Revenue TTM = 1.01b USD
EBIT TTM = 205.6m USD
EBITDA TTM = 601.6m USD
Long Term Debt = 5.55b USD (from longTermDebt, last fiscal year)
Short Term Debt = 5.75b USD (from shortTermDebt, last quarter)
Debt = 5.76b USD (from shortLongTermDebtTotal, last quarter) + Leases 10.8m
Net Debt = 5.40b USD (calculated: Debt 5.76b - CCE 355.0m)
Enterprise Value = 7.68b USD (2.28b + Debt 5.76b - CCE 355.0m)
Interest Coverage Ratio = 0.75 (Ebit TTM 205.6m / Interest Expense TTM 274.1m)
EV/FCF = 40.23x (Enterprise Value 7.68b / FCF TTM 190.9m)
FCF Yield = 2.49% (FCF TTM 190.9m / Enterprise Value 7.68b)
FCF Margin = 18.95% (FCF TTM 190.9m / Revenue TTM 1.01b)
Net Margin = -2.27% (Net Income TTM -22.9m / Revenue TTM 1.01b)
Gross Margin = 63.18% ((Revenue TTM 1.01b - Cost of Revenue TTM 371.0m) / Revenue TTM)
Gross Margin QoQ = 63.19% (prev 63.73%)
Tobins Q-Ratio = 0.80 (Enterprise Value 7.68b / Total Assets 9.55b)
Interest Expense / Debt = 4.76% (Interest Expense 274.1m / Debt 5.76b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 162.4m (EBIT 205.6m * (1 - 21.00%))
Current Ratio = 2.13 (Total Current Assets 488.6m / Total Current Liabilities 229.6m)
Debt / Equity = 3.13 (Debt 5.76b / totalStockholderEquity, last quarter 1.84b)
Debt / EBITDA = 8.98 (Net Debt 5.40b / EBITDA 601.6m)
Debt / FCF = 28.30 (Net Debt 5.40b / FCF TTM 190.9m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.24% (Net Income -22.9m / Total Assets 9.55b)
RoE = -1.21% (Net Income TTM -22.9m / Total Stockholder Equity 1.89b)
RoCE = 2.76% (EBIT 205.6m / Capital Employed (Equity 1.89b + L.T.Debt 5.55b))
RoIC = 1.08% (NOPAT 162.4m / Invested Capital 15.0b)
WACC = 5.05% (E(2.28b)/V(8.03b) * Re(8.31%) + D(5.76b)/V(8.03b) * Rd(4.76%) * (1-Tc(0.21)))
Discount Rate = 8.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 90.95 | Cagr: 0.04%
[DCF] Terminal Value 77.97% ; FCFF base≈165.3m ; Y1≈189.5m ; Y5≈278.9m
[DCF] Fair Price = N/A (negative equity: EV 4.20b - Net Debt 5.40b = -1.20b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.10 | # QB: 0
Revenue Correlation: 41.37 | Revenue CAGR: 0.76% | SUE: 1.15 | # QB: 1
EPS current Quarter (2026-09-30): EPS=-0.04 | Chg30d=+18.36% | Revisions=-40% | Analysts=3
EPS current Year (2026-12-31): EPS=-0.09 | Chg30d=+31.35% | Revisions=-25% | GrowthEPS=-204.9% | GrowthRev=+1.8%
EPS next Year (2027-12-31): EPS=-0.11 | Chg30d=+22.27% | Revisions=+0% | GrowthEPS=-11.7% | GrowthRev=+2.7%
[Analyst] Revisions Ratio: -38% (up=1, down=4)